Monopar Therapeutics Inc
NASDAQ:MNPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Henkel AG & Co KGaA
XETRA:HEN3
|
DE |
During the last 3 months Monopar Therapeutics Inc insiders bought 104.9k USD , and have not sold any shares. The stock price has dropped by 21% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/mnpr/vs/indx/gspc">open performance analysis).
The last transaction was made on
Dec 26, 2025
by
Vu Quan Anh
, who
bought
104.9k USD
worth of
MNPR shares.
During the last 3 months Monopar Therapeutics Inc insiders bought 104.9k USD , and have not sold any shares. The stock price has dropped by 21% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/mnpr/vs/indx/gspc">open performance analysis).
The last transaction was made on
Dec 26, 2025
by
Vu Quan Anh
, who
bought
104.9k USD
worth of
MNPR shares.
Monopar Therapeutics Inc
Glance View
Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Wilmette, Illinois and currently employs 9 full-time employees. The company went IPO on 2019-12-19. The firm is primarily focused on developing therapeutics designed for cancer patients. Its product pipeline includes Validive, camsirubicin, MNPR-101, and MNPR-202. The Validive is a first-in-class mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis (SOM) in oropharyngeal cancer patients. Its camsirubicin is a clinical stage topoisomerase II-alpha selective novel analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart. Its MNPR-101 is a humanized monoclonal antibody designed to bind a specific cell surface receptor found on cancer cells, the urokinase plasminogen activator receptor (uPAR), and to interrupt several pathways required for tumor growth and progression. The MNPR-202 is an early stage camsirubicin analog for various cancers.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.